Padmavathi Jonnalagadda, MD | |
3438 John F Kennedy Blvd, Jersey City, NJ 07307-4166 | |
(201) 420-0366 | |
(201) 420-6422 |
Full Name | Padmavathi Jonnalagadda |
---|---|
Gender | Female |
Speciality | Hospitalist |
Experience | 28 Years |
Location | 3438 John F Kennedy Blvd, Jersey City, New Jersey |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144228891 | NPI | - | NPPES |
DB2462 | Other | NJ | RAILROAD MEDICARE GROUP # |
9006508 | Medicaid | NJ | |
0036536 | Medicaid | NJ | |
043714808 | Other | NJ | HORIZON B/ C B/S |
02511508 | Medicaid | NY | |
P00089969 | Other | NJ | RAILROAD MEDICARE INDIVID |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 25MA07442900 (New Jersey) | Primary |
207R00000X | Internal Medicine | 225330-1 (New York) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Valley Hospital | Ridgewood, NJ | Hospital |
Carepoint Health-christ Hospital | Jersey city, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Valley Physician Services Pc | 3577857333 | 402 |
Padmavathi Jonnalagadda Md Pa | 9234126228 | 2 |
News Archive
Researchers at Duke University have engineered a bandage that captures and holds a pro-healing molecule at the site of a bone break to accelerate and improve the natural healing process.
Children who grow up in disadvantaged neighborhoods are nearly one-third more likely to experience obesity as adults, according to new research from Cornell University.
Infectious disease researchers at The University of Texas at Austin studying the novel coronavirus were able to identify how quickly the virus can spread, a factor that may help public health officials in their efforts at containment.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Researchers in Rensselaer Polytechnic Institute's Social and Behavioral Research Lab (SBRL) are leading a study to investigate potential environmental, lifestyle, and medical variables that may contribute to the onset of Amyotrophic Lateral Sclerosis (ALS).
› Verified 4 days ago
Entity Name | Padmavathi Jonnalagadda Md Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821096504 PECOS PAC ID: 9234126228 Enrollment ID: O20040430000056 |
News Archive
Researchers at Duke University have engineered a bandage that captures and holds a pro-healing molecule at the site of a bone break to accelerate and improve the natural healing process.
Children who grow up in disadvantaged neighborhoods are nearly one-third more likely to experience obesity as adults, according to new research from Cornell University.
Infectious disease researchers at The University of Texas at Austin studying the novel coronavirus were able to identify how quickly the virus can spread, a factor that may help public health officials in their efforts at containment.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Researchers in Rensselaer Polytechnic Institute's Social and Behavioral Research Lab (SBRL) are leading a study to investigate potential environmental, lifestyle, and medical variables that may contribute to the onset of Amyotrophic Lateral Sclerosis (ALS).
› Verified 4 days ago
Entity Name | Valley Physician Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467815928 PECOS PAC ID: 3577857333 Enrollment ID: O20160802002824 |
News Archive
Researchers at Duke University have engineered a bandage that captures and holds a pro-healing molecule at the site of a bone break to accelerate and improve the natural healing process.
Children who grow up in disadvantaged neighborhoods are nearly one-third more likely to experience obesity as adults, according to new research from Cornell University.
Infectious disease researchers at The University of Texas at Austin studying the novel coronavirus were able to identify how quickly the virus can spread, a factor that may help public health officials in their efforts at containment.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Researchers in Rensselaer Polytechnic Institute's Social and Behavioral Research Lab (SBRL) are leading a study to investigate potential environmental, lifestyle, and medical variables that may contribute to the onset of Amyotrophic Lateral Sclerosis (ALS).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Padmavathi Jonnalagadda, MD 3438 John F Kennedy Blvd, Jersey City, NJ 07307-4166 Ph: (201) 420-0366 | Padmavathi Jonnalagadda, MD 3438 John F Kennedy Blvd, Jersey City, NJ 07307-4166 Ph: (201) 420-0366 |
News Archive
Researchers at Duke University have engineered a bandage that captures and holds a pro-healing molecule at the site of a bone break to accelerate and improve the natural healing process.
Children who grow up in disadvantaged neighborhoods are nearly one-third more likely to experience obesity as adults, according to new research from Cornell University.
Infectious disease researchers at The University of Texas at Austin studying the novel coronavirus were able to identify how quickly the virus can spread, a factor that may help public health officials in their efforts at containment.
ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.
Researchers in Rensselaer Polytechnic Institute's Social and Behavioral Research Lab (SBRL) are leading a study to investigate potential environmental, lifestyle, and medical variables that may contribute to the onset of Amyotrophic Lateral Sclerosis (ALS).
› Verified 4 days ago
Dr. Alita Logrono Dizon, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 377 Jersey Ave, Suite 460, Jersey City, NJ 07302 Phone: 201-332-4110 Fax: 201-332-4122 | |
Mrs. Sonia Castaneda Velasco, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 172 Newark Ave, Jersey City, NJ 07302 Phone: 201-332-4727 Fax: 201-332-4157 | |
Dr. Vladimir Znamensky, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 120 Franklin St, Jersey City, NJ 07307 Phone: 201-216-9791 Fax: 201-216-1362 | |
Saira Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Medicine Dept,3rd Floor, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Zorayda Olaya De Leon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 311 Palisade Ave, Jersey City, NJ 07307 Phone: 201-963-5500 Fax: 201-963-5563 | |
Dr. Jared Saul Krok, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2431 | |
Merwin F Richard, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Newark Ave, Ste 307, Jersey City, NJ 07306 Phone: 201-418-9111 Fax: 201-418-9118 |